title: Angioedema due to fixed dose combination of telmisartan plus ramipril.
abstract: The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin-converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension.
authors.affiliation: Department of Pharmacology and Therapeutic, Government Medical College, Jammu, Jammu and Kashmir, India.
authors.forename: Vishal R
authors.initials: VR
authors.lastname: Tandon
authors.affiliation: Department of General Medicine, Government Medical College, Jammu, Jammu and Kashmir, India.
authors.forename: Annil
authors.initials: A
authors.lastname: Mahajan
authors.affiliation: Department of Pharmacology and Therapeutic, Government Medical College, Jammu, Jammu and Kashmir, India.
authors.forename: Vijay
authors.initials: V
authors.lastname: Khajuria
authors.affiliation: Department of Pharmacology and Therapeutic, Government Medical College, Jammu, Jammu and Kashmir, India.
authors.forename: Zahid H
authors.initials: ZH
authors.lastname: Gillani
keywords: Angiotensin-converting enzyme inhibitors; Ramipril; Telmisartan; angiotensin receptor blockers; fixed dose combination